The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
Diabetes is a major cause of visual impairment among workingage adults in the United States. The proliferative form of diabetic retinopathy is associated with severe vision loss (acuity <5/200). The standard treatment in proliferative diabetic retinopathy (PDR) is panretinal photocoagulation (PRP...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2018-08-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/the-role-of-anti-vascular-endothelial-growth-factor-anti-vegf-in-the-management-of-proliferative-diabetic-retinopathy |